Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation […]
How can we increase routine adult vaccination? Read More »
The disease burden of RSV has been a tough problem for biotech R&D to solve for over 60 years. However, within the last year,
We’re conquering RSV for the young and old – but more innovation is needed Read More »
The Accelerated Approval pathway has helped deliver groundbreaking treatments to patients—including for diseases like HIV. But lately, the pathway has faced increased pressure, threatening
What’s at stake for Accelerated Approval? Read More »
Cancer is less the death sentence that it used to be. That does not mean that cancer treatment can’t be profoundly life-altering or that
NIH Innovation Zone: Meet Privo Technologies Read More »
Lessons from COVID, the Inflation Reduction Act (IRA), drug prices, drug shortages, Accelerated Approval and a lawsuit seeking to block use of an approved
FDA Commissioner Califf on COVID lessons, Accelerated Approval, and more Read More »
Patient stories and relationships are at the heart of state advocacy. “A lot of policymakers are just not aware of what our companies are,
How to build a state or regional advocacy arm Read More »
On June 6, the 2023 Biotechnology Innovation Organization (BIO) International Convention opened with remarks by Katie Couric who, in addition to being an award-winning
Katie Couric on patient advocacy, breast cancer, and biotech Read More »
A $1 million project to find groundbreaking treatments for critical illnesses using Artificial Intelligence (AI) has been announced at the 2023 Biotechnology Innovation Organization
Intellectual property (IP) protections need reform but the current Congress may not have the consensus to achieve these changes, a panel of Capitol Hill
Congress may lack consensus needed for IP reform this year, BIO panelists say Read More »
COVID was unequivocal in how it shined a light onto profound global health inequity and access issues. And nowhere was that more clear than
Vaccine manufacturing in Africa: challenges and opportunities Read More »
